ArticleCellular & molecular biology letters2026
GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform.
Jack Brydon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.